they have to keep investors in the dark, they are in trial phases, any information provided about the results of tests before trials are complete could jeopardize decades of work
Sentiment: Strong Buy
conspiracy theory......it would be something if the arbitration uncovered widespread sabotage against cel-sci and its attempt to bring multikine to market. sabotage that included inVentiv and at times the use of this m/b to deter would be investors away from the stock....
hey AL... dive & catie are just one of many that spend 100% of their posting time attacking "a worthless" stock ".
How much of your time would you invest on a stock that is "worthless"?
How come ALL the attackers use the same **SCRIPT**?
One , where there is no P3???
One where there is a R/S **OVER TWO DECADES** ago.
How much would Kersten make in ,for example , 10 years ???
With a stock price of $47 ( per SV ) doesn't that = about 94 years of salary???
Sentiment: Strong Buy
How many other stocks on Message Boards do you follow this closely, and issue dire warnings to investors? Just this one? Why?
hey dive & catie....."History repeats itself"???? How many P3's has CVM been in???
ANSWER: ONE , one that is in the VERY Late stages . How many more H&N patients to complete, 100% ??
ANSWER: 64 ( *less* as of Friday) plus the "DO OVER" patients that INVENTIV did NOT treat correctly.
Will Cel-Sci have to treat all 117 INVENTIV P3 patients ????
The FDA says 784 patients are required , NOT 880...... 880 - 117 ( INVENTIV ) =763.
*****Cel-Sci will have to treat an additional 21 INVENTIV patients ! ( 763 + 21 = 784 )*****
What does a stock chart show????
ANSWER : The closing price , the last trade of the day, which often is driven down AFTER 4 : 00 PM and is often the Low of the Day ( LOD ).
****The stock chart DOES NOT show the P3.****
How many H&N patients are there worldwide ???
ANSWER: 650 ,000 , EVERY YEAR !
With FDA MK H&N approval treating just 200.000 ( about 30% ) = $10 B , EVERY YEAR!
What is a stock price for $10 B?????
Isn't that price often 10 TIMES MORE than EPS???
If the stock is sooooo "worthless" why are you here???
YOU and an ARMY of ever changing names keeps attacking a mom & pop bio that is worthless ??
YOU are one of HUNDREDS that have nothing better to do ????
What should investors do ???
The P3 will be completed SOON!
Isn't that correct?
Sentiment: Strong Buy
funny how history repeats itself, especially with this stock. the only winners are Geert and Maxx who use this as their personal piggy bank. pumpers will bash anyone who brings up the history of this company and tell you how close this company is to be worth billions. all you need to do is pull a chart of the company for the last 30 years and see how much dilution there has been without a single real success. Look at the PRs and see how they are repeated over and over. there is nothing here for investors but pain. good luck.
Sentiment: Strong Sell
"Cel STY is an odious POS. It attracts only the most ignorant and theh most dishonest! " Thanks for admitting why you are here! I am hoping to make some money!
Will be interesting to see how enrollment went in June. We expect to see good numbers.
Very pleased with this great company. -sv
Sentiment: Strong Buy
When one takes Geert's coments at face value, one gets killed!
The probability that a POS like CVM, a peny sewer company, will prevail against a multi-billion, reputable (something Cel Sty is not!) company os zero, especially since Cel Sty is the only one of dozens of clients that claims that Inventiv (Pharmanet) screweed up its trial.
Cel STY is an odious POS. It attracts only the most ignorant and theh most dishonest!
i don't know for sure...but i don't see why not. cel-sci is getting free legal assistance...where the law firm won't get paid unless cel-sci wins....so im assuming cel-sci has a pretty good chance of winning....since lawyers usually only work for "free" when they think there's a very strong chance they'll eventually get paid. one would have to assume they like their chances of winning with cel-sci.
Great find indeed. This spring has passed and still no date for hearing. Perhaps it will be settled without formal arbitration in Inventiv's case is weak. Is that a possibility?
Cel-Sci vs InVentiv enrolment arbitration
may increase pharma vigilance in CRO
contract negotiations - experts
Case likely to trigger CROs awareness of contracts and penalties
Trial protocols are biggest source of sponsor-vendor misunderstanding
CRO payment models and contract negotiation need re-evaluation
Cel-Sci's (NYSE MKT: CVM) impending lawsuit against CRO InVentiv Health Clinical for Phase
III enrolment failure may trigger sponsors and vendors to re-examine current and future
contracts, legal experts said. Whilst the arbitration tribunal, due to begin this spring, is unlikely
to trigger a flood of litigations against CROs, the case may trigger changes in current business
practices and negotiations between both parties, they added.
Cel-Sci, an immuno-oncology drug developer, launched arbitration proceedings on October
31, 2013 against InVentiv Health Clinical, claiming Pharmanet, a CRO owned by InVentiv,
breached contract and committed fraud in the inducement. Between January 2011 and April
2013, when Cel-Sci terminated the contract, the CRO enrolled only 117 of 880 required
patients for a Phase III study of Multikine (leukocyte Interleukin injection) in head and neck
cancer, said Cel-Sci CEO Geert Kersten. He said he is seeking USD 50m in direct damages,
and over USD 100m in consequential damages, because of delays to the pipeline and harm to
the company's reputation. Cel-Sci replaced Pharmanet with CROs Ergomed (FTSE AIM:
ERGO) and Aptiv Solutions, later acquired by ICON (NASDAQ:ICLR), in 2013, according to
Arbitration between a sponsor company and CRO has never before reached this late stage
publicly although some disputes have likely been resolved confidentially, lawyers said.
While Kersten said a win for Cel-Sci could "open the floodgates" to breach-of-contract
litigation brought by other pharma companies against CROs, he said the cost of legal action
might prove off-putting, especially if a CRO believes it can "grind down" a smaller opponent
Move up in the world now with the help of UltimateStockAlerts , they’ll help you flesh out winners all week and month long, trust me
It's like proving Hillary intentionally lied about Benghazi. I can't prove it, but it all points to it and Geert alluded to it. The size of the settlement and the nondisclosure around it will tell the story. There is a massive manipulation conspiracy around this stock. Laugh all you want, Cassandra (Mark David).